Related Experiment Video

Updated: Jun 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

A novel PIK3CA hotspot mutation in Isfahanian breast cancer patients

Sedigheh Gharbi1, Mehri Faghihi, Manoochehr Tavassoli

  • 1Department of Biology, Faculty of Sciences, University of Isfahan, Hezar-Jarib, Isfahan, Iran.

Cancer Investigation
|February 25, 2011
PubMed

Insights

This study investigated phosphatidylinositol 3-kinase (PI3K) gene mutations in Iranian breast cancer patients. A novel mutation hotspot in PIK3CA exon 20 was identified, distinct from previously known sites.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Somatic mutations in the phosphatidylinositol 3-kinase (PI3K) catalytic subunit (PIK3CA) gene are implicated in tumorigenesis.
  • Understanding PIK3CA mutation patterns is crucial for breast cancer research.

Purpose of the Study:

  • To investigate the frequency and spectrum of PIK3CA mutations in a cohort of Iranian breast cancer patients.
  • To identify potential novel mutation hotspots within the PIK3CA gene.

Main Methods:

  • Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) was employed to screen for mutations.
  • Direct sequencing was used to confirm identified mutations.
  • Samples included 50 breast cancer tissues, 5 normal breast tissues, and 50 normal blood samples from Iranian patients.

Main Results:

  • The overall frequency of PIK3CA mutations in the studied breast cancer samples was 14%.
  • Previously identified hotspot mutations in exon 20 were notably absent.
  • A new mutation hotspot was discovered in exon 20, present in 3 out of 50 samples.

Conclusions:

  • The findings suggest a distinct PIK3CA mutation profile in the Iranian breast cancer population.
  • The identification of a novel mutation hotspot in exon 20 warrants further investigation for its role in breast cancer development.

More Related Videos

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...